XLO Next Earnings Date Notes

— Xilio Therapeutics (NASDAQ: XLO) is a clinical-stage biotechnology company focused on discovering & developing tumor-activated immuno-oncology therapies—innovative treatments designed to unleash the power of the immune system specifically within tumors, while sparing healthy tissues. Their core pipeline includes tumor-selective cytokines and checkpoint inhibitors, with lead programs such as XTX101 (a tumor-selective anti-CTLA-4) and XTX202 (a tumor-selective IL-2). For an investor following XLO's earnings, key business metrics to track include updates on clinical trial enrollment & topline data, pipeline progress (such as new IND submissions or advancement of assets into later trial phases), cash burn rate & liquidity runway, as well as strategic partnerships or licensing deals. Since Xilio is pre-revenue and not currently commercializing products, traditional revenue and profit metrics are less relevant; instead, R&D expenses, cash position, and clarity on timelines for achieving major clinical milestones will be crucial for understanding their long-term prospects. Listening for management's guidance on these fronts during the earnings call will provide critical insight into how effectively Xilio is executing on its scientific ambitions and managing its financial resources. The next projected earnings date for XLO is 8/13/2026 7:00 am (stay tuned for a confirmed earnings date once announced).

XLO Next Earnings Date FAQ

On this page we presented the XLO Next Earnings Date information for Xilio Therapeutics along with recent past earnings dates. For Q1 of 2026, XLO reported earnings of -0.580/share, with the earnings report taking place on 5/12/2026. For Q4 of 2025, XLO reported earnings of 0.810/share, with the earnings report taking place on 3/23/2026. For Q3 of 2025, XLO reported earnings of -1.540/share, with the earnings report taking place on 11/13/2025. For Q2 of 2025, XLO reported earnings of -2.240/share, with the earnings report taking place on 8/14/2025. For Q1 of 2025, XLO reported earnings of -2.520/share, with the earnings report taking place on 5/8/2025. Based on these past earnings dates, the projected next earnings date for XLO is 8/13/2026 7:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Xilio Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Xilio Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Xilio Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next XLO earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up XLO's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the XLO next earnings date.